Agrify Corp

For the period ended Dec 31, 2023. Filed Apr 15, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 15, 2024

RYM$16.43-3.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders’ Deficit

(In thousands)

Common Stock · Preferred Stock · Preferred A Stock · Additional Paid-In- · Accumulated · Total Stockholders’ Equity (Deficit) attributable to · Non- Controlling · Total Stockholders’ Equity
	Shares	Amount	Shares	Amount	Shares	Amount	Capital	Deficit	Agrify	Interests	(Deficit)
Balance at January 1, 2022	111,035	$—	—	$—	—	$—	$196,034	$(58,975)	$137,059	$365	$137,424
Stock-based compensation	—	—	—	—	—	—	4,319	—	4,319	—	4,319
Issuance of Common Stock, warrants, and prefunded warrants in private placement	20,105	—	—	—	—	—	14,824	—	14,824	—	14,824
Confidentially marketed public offering	594,232	1	—	—	—	—	3,269	—	3,270	—	3,270
Issuance of Common Stock through an “at the market” offering, net of fees	306,628	—	—	—	—	—	15,042	—	15,042	—	15,042
Common Stock issued for contingent liabilities	435	—	—	—	—	—	2,220	—	2,220	—	2,220
Acquisition of Lab Society	2,128	—	—	—	—	—	1,904	—	1,904	—	1,904
Exercise of options	43	—	—	—	—	—	20	—	20	—	20
Exercise of warrants	2,443	—	—	—	—	—	243	—	243	—	243
Vesting of restricted stock units	1,249	—	—	—	—	—	—	—	—	—	—
Net Loss	—	—	—	—	—	—	—	(188,173)	(188,173)	(134)	(188,307)
Balance at December 31, 2022	1,038,298	$1	—	$—	—	$—	$237,875	$(247,148)	$(9,272)	$231	$(9,041)

Common Stock · Preferred Stock · Preferred A Stock · Additional Paid-in- · Accumulated · Total Stockholders’ Deficit attributable to · Non- Controlling · Total Stockholders’
	Shares	Amount	Shares	Amount	Shares	Amount	Capital	Deficit	Agrify	Interests	Deficit
Balance at January 1, 2023	1,038,298	$1	—	$—	—	$—	$237,875	$(247,148)	$(9,272)	$231	$(9,041)
Stock-based compensation	—	—	—	—	—	—	2,662	—	2,662	—	2,662
Issuance of Common Stock through an “at the market” offering, net of fees	323,082	—	—	—	—	—	1,545	—	1,545	—	1,545
Issuance of held-back shares to Lab Society	499	—	—	—	—	—	—	—	—	—	—
Issuance of Common Stock to Pure Pressure	366	—	—	—	—	—	—	—	—	—	—
Vesting of restricted stock units	17	—	—	—	—	—	—	—	—	—	—
Exercise of prefunded warrants in private placement	84,962	—	—	—	—	—	—	—	—	—	—
Issuance of equity classified warrants	—	—	—	—	—	—	1,554	—	1,554	—	1,554
Exchange of private placement debt into equity classified warrants	—	—	—	—	—	—	3,877	—	3,877	—	3,877
Conversion of Exchange Note	69,567	—	—	—	—	—	2,146	—	2,146	—	2,146
Conversion of Convertible Note	153,617	1	—	—	—	—	1,171	—	1,172	—	1,172
Proceeds from Employee Stock Purchase Plan Shares	2,500	—	—	—	—	—	25	—	25	—	25
Reverse stock split fractional share settlement	28,335	—	—	—	—	—	—	—	—	—	—
Net loss	—	—	—	—	—	—	—	(18,649)	(18,649)	(1)	(18,650)
Balance December 31, 2023	1,701,243	$2	—	$—	—	$—	$250,855	$(265,797)	$(14,940)	$230	$(14,710)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.